This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Other Psychiatric Disorders. Part II: Special Considerations

Stephen R. Marder, M.D.; Dilip V. Jeste, M.D.; and Joseph P. McEvoy, M.D.

Published: June 15, 1998

Article Abstract

Click to enlarge page

Indications for atypical antipsychotics other than schizophrenia so far have included bipolar disorder, major depression, schizoaffective disorder, dementia, delirium, obsessive-compulsive disorder, Tourette’s syndrome, and mental retardation, Dr. Prakash S. Masand reported. In 1997, only 38% of risperidone prescriptions in the United States were for the treatment of schizophrenia, while 20% were for bipolar disorder, 11% for dementia, and the rest (31%) for the other disorders listed above.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 59

Quick Links: